Big Move For Synthorx, Inc.

Synthorx, Inc. (THOR:NASDAQ) jumped higher at $67.71, representing a gain of 170.5%. On Fri 06 Dec 19, THOR:NASDAQ hit a New 2-Week High of $25.03. The stock got featured on our News Catalysts scanner on Mon 09 Dec 19 at 02:06 PM in the 'INVESTOR UPDATE' category. From Fri 15 Nov 19, the stock recorded 71.43% Up Days and 73.33% Green Days

About Synthorx, Inc. (THOR:NASDAQ)

Synthorx Inc is a biopharmaceutical company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. The company through its platform technology expands the genetic code by adding a new DNA base pair. Its lead product candidate includes THOR-707 a variant of IL-2 designed to kill tumor cells. It uses the Expanded Genetic Alphabet platform technology to develop cytokine Synthorins. It has designed cytokine Synthorin programs, including IL-2, IL-10 and IL-15, for the treatment of cancer, and another IL-2 Synthorin program for the treatment of autoimmune disorders.